Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
European Journal of Cardiovascular Nursing
|
June 13, 2025
Clinical service organisation for adults with atrial fibrillation: Cochrane systematic review and meta-analysis
C Ferguson, F Shaikh, S M Allida, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1990
Products of the polymerase-encoding region of the coronavirus IBV
I Brierley, M E Boursnell, M M Binns, et al.
The EMBO Journal
|
December 1, 1987
An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV
I Brierley, M E Boursnell, M M Binns, et al.
Research in Social & Administrative Pharmacy : RSAP
|
August 4, 2016
Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease
L Franco-Trigo, L N Hossain, D Durks, et al.
The Journal of Infectious Diseases
|
November 1, 1994
Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1
C S McLean, M Erturk, R Jennings, et al.
Biochemistry
|
July 6, 1993
Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5
S H Northrup, K A Thomasson, C M Miller, et al.
Vaccine
|
November 1, 1996
Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer
M E Boursnell, E Rutherford, J K Hickling, et al.
Human Gene Therapy
|
October 30, 1999
High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H
X Zhang, M De Alwis, S L Hart, et al.
The Journal of Infectious Diseases
|
January 1, 1997
A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease
M E Boursnell, C Entwisle, D Blakeley, et al.
Advances in Experimental Medicine and Biology
|
February 23, 1999
Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer
M E Boursnell, C Entwisle, S A Ali, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
European Journal of Cardiovascular Nursing
|
June 13, 2025
Clinical service organisation for adults with atrial fibrillation: Cochrane systematic review and meta-analysis
C Ferguson, F Shaikh, S M Allida, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1990
Products of the polymerase-encoding region of the coronavirus IBV
I Brierley, M E Boursnell, M M Binns, et al.
The EMBO Journal
|
December 1, 1987
An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV
I Brierley, M E Boursnell, M M Binns, et al.
Research in Social & Administrative Pharmacy : RSAP
|
August 4, 2016
Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease
L Franco-Trigo, L N Hossain, D Durks, et al.
The Journal of Infectious Diseases
|
November 1, 1994
Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1
C S McLean, M Erturk, R Jennings, et al.
Biochemistry
|
July 6, 1993
Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5
S H Northrup, K A Thomasson, C M Miller, et al.
Vaccine
|
November 1, 1996
Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer
M E Boursnell, E Rutherford, J K Hickling, et al.
Human Gene Therapy
|
October 30, 1999
High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H
X Zhang, M De Alwis, S L Hart, et al.
The Journal of Infectious Diseases
|
January 1, 1997
A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease
M E Boursnell, C Entwisle, D Blakeley, et al.
Advances in Experimental Medicine and Biology
|
February 23, 1999
Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer
M E Boursnell, C Entwisle, S A Ali, et al.
Page
of 5